Home Cart Sign in  
Chemical Structure| 1035688-66-4 Chemical Structure| 1035688-66-4

Structure of Farudodstat
CAS No.: 1035688-66-4

Chemical Structure| 1035688-66-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Farudodstat is a selective neutrophil elastase (NE) inhibitor with high affinity for NE, with an IC50 value of 10 nM. Farudodstat exhibits anti-inflammatory and anti-tissue damage effects and can be used in research on pulmonary diseases and other inflammatory conditions.

Synonyms: ASLAN003

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Farudodstat

CAS No. :1035688-66-4
Formula : C19H14F2N2O3
M.W : 356.32
SMILES Code : O=C(O)C1=C(NC2=C(F)C=C(C3=CC=CC(OC)=C3)C=C2F)N=CC=C1
Synonyms :
ASLAN003
MDL No. :MFCD32215342
InChI Key :OMPATGZMNFWVOH-UHFFFAOYSA-N
Pubchem ID :24986824

Safety of Farudodstat

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SUM44TAMR cells 7.5-20 µM 120 hours Inhibits DHODH, enhancing tamoxifen efficacy in resistant cells PMC11761122
MB134TAMR cells 7.5-20 µM 120 hours Inhibits DHODH, enhancing tamoxifen efficacy in resistant cells PMC11761122

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03451084 Acute Myeloid Leukemia PHASE2 COMPLETED 2019-12-13 1 Site, Louisville, Kentucky, ... More >>40241, United States|1 Site, Albury, New South Wales, Australia|3 Sites, Darlinghurst, New South Wales, Australia|1 Site, Waratah, New South Wales, Australia|1 Site, Douglas, Queensland, Australia|1 Site, Adelaide, South Australia, Australia|3 Sites, Melbourne, Victoria, Australia|3 Sites, Singapore, Singapore Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.81mL

0.56mL

0.28mL

14.03mL

2.81mL

1.40mL

28.06mL

5.61mL

2.81mL

 

Historical Records

Categories